A. Ferrant
Impact in
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Biochemistry top 10%
- Blood transfusion and management
Papers in
-
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 2
- Chronic Myeloid Leukemia Treatments 1
- Iron Metabolism and Disorders 1
-
- Blood transfusion and management 1
- Co-authors
- Julie Anne Simpson (1 shared paper)S. Mitchell Lewis (1 shared paper)T. C. Pearson (1 shared paper)Giovanni Barosi (1 shared paper)Yves Najean (1 shared paper)Susan Chinn (1 shared paper)C. Vermylen (1 shared paper)Jl. Michaux (1 shared paper)
In The Last Decade
A. Ferrant
9 papers receiving 337 citations
Peers
Comparison fields: 5 of 45
- Genetics 81
- Biochemistry 51
- Hematology 51
- Critical Care and Intensive Care Medicine 6
- Surgery 53
Countries citing papers authored by A. Ferrant
This map shows the geographic impact of A. Ferrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ferrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ferrant more than expected).
Fields of papers citing papers by A. Ferrant
This network shows the impact of papers produced by A. Ferrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ferrant. The network helps show where A. Ferrant may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Ferrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 270 | |
| 2 | 1994 | 47 | |
| 3 | 2010 | 35 | |
| 4 | 1993 | 4 | |
| 5 | Domperidone (R 33812) in the prophylactic treatment of chemotherapy-induced emesis. A multicentre evaluation. | 1978 | 2 |
| 6 | Cytogenetic risk group and cytogenetic response predict outcome of patients with poor-risk mds and secondary aml treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA leukemia groups | 2001 | 1 |
| 7 | The impact of post-remission therapy on outcome of patients with poor-risk AIDS and secondary AML treated with intensive chemotherapy with or without stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAK, HOVON, Scandinavian, and the Gimema leukemia groups | 2003 | 1 |
| 8 | 2005 | 1 | |
| 9 | 2007 | 1 | |
| 10 | 1973 | 0 |
About A. Ferrant
A. Ferrant is a scholar working on Hematology, Biochemistry, Emergency Medicine, Oncology and Physiology, having authored 10 papers that have together received 362 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Iron Metabolism and Disorders (1 paper), Clinical Laboratory Practices and Quality Control (1 paper), Blood transfusion and management (1 paper), Nausea and vomiting management (1 paper) and Hematological disorders and diagnostics (1 paper). The work is most often cited by research in Genetics (81 citations), Biochemistry (51 citations), Hematology (51 citations), Critical Care and Intensive Care Medicine (6 citations) and Surgery (53 citations). A. Ferrant has collaborated with scholars based in Belgium, Italy and France. Frequent co-authors include Julie Anne Simpson, S. Mitchell Lewis, T. C. Pearson, Giovanni Barosi, Yves Najean, Susan Chinn, C. Vermylen, Jl. Michaux, Philippe Martiat and Guy Cornu. Their work appears in journals such as Blood, British Journal of Haematology, Annals of Hematology, Leukemia and Acta Clinica Belgica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.